𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of stem cell marker CD133 expression with dissemination of glioblastomas

✍ Scribed by Atsushi Sato; Kaori Sakurada; Toshihiro Kumabe; Toshio Sasajima; Takaaki Beppu; Kenichiro Asano; Hiroki Ohkuma; Akira Ogawa; Kazuo Mizoi; Teiji Tominaga; Chifumi Kitanaka; Takamasa Kayama; for the Tohoku Brain Tumor Study Group

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
336 KB
Volume
33
Category
Article
ISSN
0344-5607

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Epigenetic regulation of cancer stem cel
Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-Ξ²
✍ Hanning You; Wei Ding; C. Bart Rountree πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 463 KB πŸ‘ 1 views

Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem cells and cancer stem cells in various tissues including liver. CD133 expression has been recently linked to poor prognosis

CD133 and ALDH may be the molecular mark
CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells
✍ Min Wang; Juan Xiao; Jianxin Jiang; Renyi Qin πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 95 KB

## Dear Editor, We read the comments of Angela Gradilone et al. on our article ''Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.'' The authors concluded that CD133 and ALDH1 are two other molecular markers of putative cancer stem

In vivo investigation of CD133 as a puta
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line
✍ Xu Dong Wei; Liang Zhou; Lei Cheng; Jie Tian; Jack J. Jiang; Julia MacCallum πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 329 KB

## Abstract ## Background Mounting evidence suggests that most tumors consist of a heterogeneous population of cells with a subset population that has the exclusive tumorigenic ability. They are called cancer stem cells (CSCs). CSCs can self‐renew to generate additional CSCs and also differentiate